Gemzar and dyspnoea 
Gemzar and dyspnoea Patient Reports February 13, 2012
Gemzar Side Effects Report #4564331-7
Gemzar side effect was reported by a Physician from on Jan 10, 2005. Male patient, 65 years of age, was diagnosed with ureteric cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: atelectasis, dyspnoea, haematuria, interstitial lung disease, lung infiltration, lymphadenopathy mediastinal, pancytopenia, pleural effusion, pneumonia
. Gemzar dosage: 1000 MG/M2. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.Gemzar Side Effects Report #5030028-2
Gemzar side effect was reported by a Consumer or non-health professional from GERMANY on May 29, 2006. Female patient, 77 years of age, was diagnosed with transitional cell carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, blood creatinine increased, c-reactive protein increased, cardiac failure, dyspnoea, hypersensitivity, leukopenia, oedema peripheral, pleural effusion. Gemzar dosage: unknown. During the same period patient was treated with NORVASC, CORTICOSTEROIDS. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #4777829-3
Gemzar side effect was reported by a Physician from FRANCE on Aug 29, 2005. Male patient, 66 years of age, weighting 154.3 lb, was diagnosed with squamous cell carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anorexia, cough, crepitations, dyspnoea, interstitial lung disease, lung disorder, pneumonitis, pyrexia. Gemzar dosage: 1250 MG/M2/2 OTHER. During the same period patient was treated with CISPLATIN, NEULASTA, NOVATREX, PREDNISONE, SPECIAFOLDINE, ACTONEL. Patient was hospitalized. Patient died on 05/04/2005.
Gemzar Side Effects Report #5511195-0
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 01, 2007. Male patient, 80 years of age, weighting 150.0 lb, was diagnosed with small intestine carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cough, cyanosis, dyspnoea, hypoxia. Gemzar dosage: 1000 MG/M2, UNK. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5828742-1
Gemzar side effect was reported by a Physician from UNITED STATES on July 23, 2008. Male patient was diagnosed with prostate cancer
and was treated with Gemzar. After drug was administered, patient experienced the following side effects: dyspnoea, neutropenia, pneumonia , sepsis . Gemzar dosage: 750 MG/M2, UNK. During the same period patient was treated with EPOTHILONE B. Patient was hospitalized. Patient died.Gemzar Side Effects Report #4781685-7
Gemzar side effect was reported by a Physician from JAPAN on Sept 09, 2005. Male patient, 52 years of age, weighting 88.18 lb, was diagnosed with pleural mesothelioma malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: bone marrow depression, cardiac arrest
, dyspnoea, hepatic function abnormal, malaise, pleural effusion, pulmonary hypertension , pyrexia. Gemzar dosage: 800 MG/M2 OTHER. During the same period patient was treated with CISPLATIN, VINORELBINE. Patient was hospitalized. Patient died on 10/29/2002.Gemzar Side Effects Report #5197084-2
Gemzar side effect was reported by a Physician from JAPAN on Dec 20, 2006. Male patient, 73 years of age, weighting 109.8 lb, was diagnosed with pancreatic carcinoma stage iv, prophylaxis of nausea and vomiting and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bone marrow failure, chest x-ray abnormal, dyspnoea, haemoglobin decreased, hepatic enzyme increased, interstitial lung disease, platelet count decreased. Gemzar dosage: 1400 MG, OTHER. During the same period patient was treated with KYTRIL, DECADRON #. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5186319-8
Gemzar side effect was reported by a Physician from JAPAN on Dec 01, 2006. Male patient, 73 years of age, weighting 109.8 lb, was diagnosed with pancreatic carcinoma stage iv, prophylaxis of nausea and vomiting and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bone marrow failure, chest x-ray abnormal, dyspnoea, hepatic enzyme increased, interstitial lung disease, pleural effusion, rash
. Gemzar dosage: 1400 MG, OTHER. During the same period patient was treated with KYTRIL, DECADRON #. Patient was hospitalized. Patient recovered.Gemzar Side Effects Report #5303237-2
Gemzar side effect was reported by a Physician from JAPAN on Apr 11, 2007. Male patient, 72 years of age, weighting 123.5 lb, was diagnosed with pancreatic carcinoma stage iv, prophylaxis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cardiac failure, dyspnoea, haemoglobin decreased, infection
, oedema, palpitations, pleural effusion. Gemzar dosage: 1500 MG, OTHER. During the same period patient was treated with WARFARIN POTASSIUM. Patient was hospitalized. Patient recovered.Gemzar Side Effects Report #4595848-7
Gemzar side effect was reported by a Physician from on Feb 09, 2005. Male patient, 72 years of age, weighting 127.9 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anorexia, back pain
, bone marrow depression, cancer pain, cerebral infarction, constipation , dysgeusia, dyspnoea, malaise. Gemzar dosage: 1500 MG OTHER. During the same period patient was treated with TICLOPIDINE, PURSENNID. Patient was hospitalized. Patient died on 10/25/2004.Gemzar Side Effects Report #4600326-2
Gemzar side effect was reported by a Physician from on Feb 10, 2005. Female patient, 63 years of age, weighting 127.9 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: back pain
, cerebral artery stenosis, cerebral infarction, dysarthria, dyspnoea, echocardiogram abnormal, electrocardiogram abnormal, malignant neoplasm progression, myocardial infarction. Gemzar dosage: 1400 MG OTHER. Patient was hospitalized and became disabled. Patient recovered.Gemzar Side Effects Report #4562960-8
Gemzar side effect was reported by a Physician from on Dec 27, 2004. Male patient, 62 years of age, weighting 103.6 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, blood bicarbonate increased, blood ph decreased, body temperature increased, bone marrow depression, c-reactive protein increased, chest x-ray abnormal, dyspnoea, effusion. Gemzar dosage: 800 MG/1 WEEK. During the same period patient was treated with BERIZYM, GASMOTIN, AMOBAN, NAUZELIN, MECOBALAMIN. Patient recovered.
Gemzar Side Effects Report #4848700-3
Gemzar side effect was reported by a Physician from JAPAN on Nov 18, 2005. Male patient, 60 years of age, weighting 135.8 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, dyspnoea, gastritis, gastrointestinal haemorrhage, haemoptysis, ileus paralytic, malignant ascites, malignant pleural effusion, metastases to lymph nodes. Gemzar dosage: 1000 MG, OTHER, INTRAVENOUS. During the same period patient was treated with PENTAZOCINE LACTATE, NSAID, OXYCODONE, MORPHINE. Patient died.
Gemzar Side Effects Report #4851375-0
Gemzar side effect was reported by a Physician from JAPAN on Nov 18, 2005. Male patient, 60 years of age, weighting 135.8 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, asthenia, condition aggravated, cough, dyspnoea, gastritis, gastrointestinal haemorrhage, malignant ascites, malignant pleural effusion. Gemzar dosage: 1000 MG, OTHER, INTRAVENOUS. During the same period patient was treated with PENTAZOCINE LACTATE, NSAID, OXYCODONE, MORPHINE. Patient died.
Gemzar Side Effects Report #4932073-1
Gemzar side effect was reported by a Physician from JAPAN on Feb 06, 2006. Male patient, 60 years of age, weighting 135.8 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal pain lower, anaemia, back pain
, cough, dyspnoea, gastritis, gastrointestinal haemorrhage, haematemesis, haemoptysis. Gemzar dosage: 1000 MG, OTHER, INTRAVENOUS. During the same period patient was treated with PENTAZOCINE LACTATE, NSAID, OXYCODONE, MORPHINE. Patient died.Gemzar Side Effects Report #4760331-2
Gemzar side effect was reported by a Physician from JAPAN on Aug 11, 2005. Male patient, 62 years of age, weighting 110.2 lb, was diagnosed with pancreatic carcinoma recurrent and was treated with Gemzar. After drug was administered, patient experienced the following side effects: chlamydial infection, cough, cytomegalovirus antibody positive, difficulty in walking, dyspnoea, hypoaesthesia, lymphocyte stimulation test positive, metastases to spine, paresis. Gemzar dosage: 1400 MG OTHER. During the same period patient was treated with VOLTAREN SUPPOSITORIES, MS CONTIN. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5314840-8
Gemzar side effect was reported by a Physician from on Apr 26, 2007. Male patient, 61 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alveolitis, dyspnoea, pyrexia. Gemzar dosage: 1000 MG/M2, OTHER. During the same period patient was treated with RANIDIL, DEXAMETHASONE, ZOFRAN, GLIBOMET. Patient recovered.
Gemzar Side Effects Report #5052182-9
Gemzar side effect was reported by a Pharmacist from UNITED STATES on July 12, 2006. Male patient, 59 years of age, weighting 209.4 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: dyspnoea, hypoxia, lung disorder, lung infection, pain
, pneumonitis, pulmonary oedema, respiratory failure. Gemzar dosage: unknown. During the same period patient was treated with IV PAIN MEDS, DILAUDID, TORADOL, TYLENOL ATC, OXYCONTIN, LASIX, BUMEX. Patient died on 07/10/2006.Gemzar Side Effects Report #5145282-6
Gemzar side effect was reported by a Physician from FRANCE on Oct 27, 2006. Male patient, 49 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: dyspnoea. Gemzar dosage: unknown. Patient died.
Gemzar Side Effects Report #5743869-0
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on May 07, 2008. Male patient, 45 years of age, was diagnosed with pancreatic carcinoma metastatic, pancreatic carcinoma recurrent, nausea
and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal pain lower, arthralgia, blood creatinine increased, cardiac failure congestive, chills, dyspnoea, fatigue, fluid retention, gastrointestinal pain. Gemzar dosage: unknown. During the same period patient was treated with TARCEVA, AVASTIN, NIFEDIPINE, CARAFATE, BICARBONATE, BICARBONATE, LORAZEPAM. Patient was hospitalized. Patient recovered.Gemzar Side Effects Report #5764704-0
Gemzar side effect was reported by a Physician from UNITED STATES on May 29, 2008. Male patient, 45 years of age, was diagnosed with pancreatic carcinoma metastatic, pancreatic carcinoma recurrent, nausea
and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal pain lower, arthralgia, blood creatinine increased, cardiac failure congestive, chills, dyspnoea, fatigue, fluid retention, gastrointestinal pain. Gemzar dosage: unknown. During the same period patient was treated with TARCEVA, AVASTIN, NIFEDIPINE, CARAFATE, BICARBONATE, BICARBONATE, LORAZEPAM. Patient was hospitalized. Patient recovered.Gemzar Side Effects Report #5836629-3
Gemzar side effect was reported by a Physician from UNITED STATES on July 29, 2008. Male patient, 45 years of age, was diagnosed with pancreatic carcinoma metastatic, pancreatic carcinoma recurrent, nausea
and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal pain lower, arthralgia, blood creatinine increased, cardiac failure congestive, chills, dyspnoea, fatigue, fluid retention, gastrointestinal pain. Gemzar dosage: unknown. During the same period patient was treated with TARCEVA, AVASTIN, NIFEDIPINE, CARAFATE, BICARBONATE, BICARBONATE, LORAZEPAM. Patient was hospitalized. Patient died on 07/25/2008.Gemzar Side Effects Report #4723848-2
Gemzar side effect was reported by a Health Professional from UNITED STATES on June 30, 2005. Female patient, 77 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, cellulitis
, cough, dehydration, dyspnoea, emphysema, lung disorder, lung neoplasm, malnutrition. Gemzar dosage: unknown. During the same period patient was treated with VICODIN, POLYETHYLENE GLYCOL, CITRUCEL, PANCRELIPASE. Patient was hospitalized. Patient recovered.Gemzar Side Effects Report #4778005-0
Gemzar side effect was reported by a Physician from DENMARK on Sept 06, 2005. Female patient, 74 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, aortic atherosclerosis, aortic valve incompetence, carbohydrate antigen 19-9 increased, cardiac failure, cardiomegaly, chills, dyspnoea, electrocardiogram poor r-wave progression. Gemzar dosage: 1000 MG/M2 ONCE PER WEEK FOR THREE WEEKS. During the same period patient was treated with LEVOTHYROXINE, KREON, PANTOPRAZOLE. Patient was hospitalized. Patient died on 08/01/2005.
Gemzar Side Effects Report #4831325-3
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 16, 2005. Male patient, 73 years of age, weighting 184.2 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cardiac failure congestive, dyspnoea, malignant neoplasm progression, metastases to liver, oedema peripheral, oxygen saturation decreased, pancreatic carcinoma, pneumonia
, productive cough. Gemzar dosage: unknown. During the same period patient was treated with LAPATINIB. Patient was hospitalized. Patient recovered.Gemzar Side Effects Report #4832377-7
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 17, 2005. Male patient, 73 years of age, weighting 184.2 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cardiac failure congestive, condition aggravated, dyspnoea, malignant neoplasm progression, metastases to liver, oedema peripheral, oxygen saturation decreased, pancreatic carcinoma, pneumonia
. Gemzar dosage: unknown. During the same period patient was treated with LAPATINIB. Patient was hospitalized. Patient recovered.Gemzar Side Effects Report #4576161-0
Gemzar side effect was reported by a Health Professional from on Feb 01, 2005. Female patient, 70 years of age, weighting 154.0 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: dyspnoea, pulmonary embolism
, splenic rupture. Gemzar dosage: 1000MG/M2 IV Q W X 7. During the same period patient was treated with ARANESP. Patient was hospitalized. Patient died on 01/28/2005.Gemzar Side Effects Report #4919790-4
Gemzar side effect was reported by a Health Professional from JAPAN on Jan 27, 2006. Male patient, 69 years of age, weighting 50.60 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood culture positive, cerebral infarction, disease progression, dyslalia, dysphagia, dyspnoea, escherichia infection, malignant pleural effusion, muscular weakness. Gemzar dosage: 1600 MG, OTHER, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5357141-4
Gemzar side effect was reported by a Health Professional from UNITED STATES on June 12, 2007. Male patient, 68 years of age, weighting 181.0 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal pain
, acute respiratory distress syndrome, chills, cholangitis, dyspnoea, pneumocystis jiroveci infection, sepsis , stent occlusion. Gemzar dosage: unknown. During the same period patient was treated with LAPATINIB. Patient died on 06/03/2007.Gemzar Side Effects Report #4620264-9
Gemzar side effect was reported by a Physician from on Mar 09, 2005. Male patient, 68 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: dyspnoea, oropharyngeal swelling. Gemzar dosage: unknown. Patient recovered.
Gemzar Side Effects Report #5170041-8
Gemzar side effect was reported by a Physician from UNITED KINGDOM on Nov 30, 2006. Male patient, 62 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: dyspnoea, erythema, face oedema, laryngeal oedema, rash
, rash maculo-papular, tachycardia. Gemzar dosage: 1425 MG, UNK. During the same period patient was treated with DEXAMETHASONE, METOCLOPRAMIDE, LORAZEPAM, PREDNISOLONE, NEUPOGEN, CITALOPRAM HYDROBROMIDE, IRON SULPHATETHIAMIN COMPOUND, LANSOPRAZOLE. Patient recovered.Gemzar Side Effects Report #5206080-8
Gemzar side effect was reported by a Physician from GERMANY on Jan 02, 2007. Male patient, 60 years of age, weighting 196.2 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cough, dyspnoea, interstitial lung disease, lung infiltration. Gemzar dosage: 1000 MG/M2, UNK. Patient recovered.
Gemzar Side Effects Report #5286549-0
Gemzar side effect was reported by a Physician from GERMANY on Mar 28, 2007. Male patient, 60 years of age, weighting 196.2 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal pain upper, cough, dyspnoea, interstitial lung disease, lung infiltration. Gemzar dosage: 1000 MG/M2, UNK. Patient recovered.
Gemzar Side Effects Report #4981726-8
Gemzar side effect was reported by a Pharmacist from UNITED STATES on Apr 20, 2006. Male patient, 59 years of age, weighting 217.0 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: capillary leak syndrome, dyspnoea, lung infiltration, oxygen saturation decreased, pneumonitis chemical, respiratory failure. Gemzar dosage: unknown. During the same period patient was treated with TARCEVA, LEVAQUIN. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5796161-2
Gemzar side effect was reported by a Physician from FRANCE on June 17, 2008. Male patient, 56 years of age, weighting 156.5 lb, was diagnosed with pancreatic carcinoma, escherichia bacteraemia, depression
, pain and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cholecystitis, disseminated intravascular coagulation, dyspnoea, interstitial lung disease, thrombocytopenia. Gemzar dosage: 1970 MG, ON DAY 1, 8 AND 15 OF 4 WEEKLY CYCLES. During the same period patient was treated with CLAMOXYL, SEROPLEX, SKENAN, OFLOCET. Patient was hospitalized. Patient recovered.Gemzar Side Effects Report #5032447-7
Gemzar side effect was reported by a Physician from UNITED STATES on June 05, 2006. Female patient, 55 years of age, weighting 159.0 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: deep vein thrombosis
, dyspnoea, fatigue, oedema peripheral. Gemzar dosage: 800 MG, WEEKLY (1/W), INTRAVENOUS. During the same period patient was treated with VOLTAREN, VICODIN, PRILOSEC, KYTRIL, SYNTESTAN, AMBIEN, PROTONIX, POTASSIUM CHLORIDE. Patient recovered.Gemzar Side Effects Report #4578543-X
Gemzar side effect was reported by a Physician from on Jan 20, 2005. Female patient, 54 years of age, weighting 110.2 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute respiratory failure, blood lactate dehydrogenase increased, c-reactive protein increased, dyspnoea, haemoglobin decreased, interstitial lung disease, lung infiltration, pleural effusion. Gemzar dosage: 1500 MG OTHER. Patient recovered.
Gemzar Side Effects Report #5149781-2
Gemzar side effect was reported by a Physician from SWITZERLAND on Oct 25, 2006. Female patient, 53 years of age, weighting 141.8 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, capillary leak syndrome, cardiomegaly, dyspnoea, hypertension, weight increased. Gemzar dosage: 1650 MG, WEEKLY (1/W). During the same period patient was treated with OMEPRAZOLE, CALCIMAGON. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5463350-6
Gemzar side effect was reported by a Physician from UNITED STATES on Sept 17, 2007. Female patient was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cyanosis, dyspnoea. Gemzar dosage: 1000 MG/M2, UNK. Patient recovered.
Gemzar Side Effects Report #5889494-2
Gemzar side effect was reported by a Physician from DENMARK on Sept 08, 2008. Male patient, weighting 220.5 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, blood creatine increased, blood urea increased, dyspnoea, nephropathy, oedema peripheral, thrombocytopenia. Gemzar dosage: unknown. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #6079360-4
Gemzar side effect was reported by a Physician from JAPAN on Feb 09, 2009. Male patient was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: dyspnoea, pleural effusion, renal failure. Gemzar dosage: 1000 MG/M2, UNK. Patient recovered.
Gemzar Side Effects Report #6104013-3
Gemzar side effect was reported by a Physician from JAPAN on Mar 02, 2009. Male patient was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: dyspnoea, pleural effusion, renal failure. Gemzar dosage: 1000 MG/M2, UNK. Patient recovered.
Gemzar Side Effects Report #4992566-8
Gemzar side effect was reported by a Health Professional from UNITED STATES on Oct 05, 2005. Male patient was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: dyspnoea, neoplasm malignant. Gemzar dosage: 1600 MG, WEEKLY (1/W), INTRAVENOUS. Patient recovered.
Gemzar Side Effects Report #5088942-8
Gemzar side effect was reported by a Physician from JAPAN on Aug 04, 2006. Female patient, 22 years of age, weighting 158.7 lb, was diagnosed with ovarian epithelial cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: asthma
, blood pressure diastolic decreased, cardio-respiratory arrest, diffuse alveolar damage, dilatation ventricular, dyspnoea, haemorrhagic ascites, hepatic congestion. Gemzar dosage: 1360 MG, OTHER, INTRAVENOUS. During the same period patient was treated with MS CONTIN, MORPHINE. Patient died on 04/27/1983.Gemzar Side Effects Report #4735285-5
Gemzar side effect was reported by a Physician from UNITED STATES on July 19, 2005. Female patient, 88 years of age, was diagnosed with ovarian cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cardiac disorder, chest pain
, dyspnoea, hypertension, ischaemia, platelet count decreased, white blood cell count decreased. Gemzar dosage: 1190 MG. During the same period patient was treated with TAXOL, CARBOPLATIN, TAXOTERE. Patient was hospitalized. Patient recovered.Gemzar Side Effects Report #4737431-6
Gemzar side effect was reported by a Physician from UNITED STATES on July 19, 2005. Female patient, 88 years of age, was diagnosed with ovarian cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cardiac disorder, chest pain
, dyspnoea, hypertension, ischaemia, platelet count decreased, white blood cell count decreased. Gemzar dosage: 1190 MG. During the same period patient was treated with TAXOL, CARBOPLATIN, TAXOTERE. Patient was hospitalized. Patient recovered.Gemzar Side Effects Report #4900376-2
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 13, 2006. Female patient, 67 years of age, was diagnosed with ovarian cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cough, deep vein thrombosis
, dyspnoea, erythema, fluid retention, oedema peripheral, pneumonia klebsiella, pulmonary embolism . Gemzar dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.Gemzar Side Effects Report #4776369-5
Gemzar side effect was reported by a Physician from JAPAN on Sept 01, 2005. Female patient, 57 years of age, weighting 141.1 lb, was diagnosed with ovarian cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, dyspnoea, venous thrombosis limb. Gemzar dosage: 1670 MG OTHER. During the same period patient was treated with WARFARIN, METHYCOBAL, ADALAT, MAGNESIUM OXIDE, DAIKENTYUTO, JUZENTAIHOTO, DECADRON, CHLOR. Patient died on 08/25/2005.
Gemzar Side Effects Report #4799834-3
Gemzar side effect was reported by a Physician from JAPAN on Sept 27, 2005. Female patient, 57 years of age, weighting 141.1 lb, was diagnosed with ovarian cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, dyspnoea, pleural effusion, venous thrombosis limb. Gemzar dosage: 1670 MG OTHER. During the same period patient was treated with WARFARIN, METHYCOBAL, ADALAT CR, MAGNESIUM OXIDE, DAIKENTYUTO, JUZENTAIHOTO, DECADRON, CHLOR. Patient died on 08/25/2005.
Gemzar Side Effects Report #5901135-4
Gemzar side effect was reported by a Physician from ISRAEL on Sept 16, 2008. Female patient, 56 years of age, was diagnosed with ovarian cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cough, dyspnoea, pleural effusion, pyrexia. Gemzar dosage: 850 MG/M2, UNK. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5087095-X
Gemzar side effect was reported by a Health Professional from TURKEY on Aug 01, 2006. Male patient, 61 years of age, weighting 154.3 lb, was diagnosed with non-small cell lung cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: bone marrow toxicity, dyspnoea, haemoglobin decreased, loss of consciousness, neutrophil percentage decreased, platelet count decreased, white blood cell count decreased. Gemzar dosage: 1800 MG, OTHER, INTRAVENOUS. During the same period patient was treated with CISPLATIN, ANTIEMETICS AND ANTINAUSEANTS, ANTIHISTAMINES, CORTICOSTEROIDS. Patient was hospitalized. Patient died on 03/11/2004.
Gemzar Side Effects Report #5708076-6
Gemzar side effect was reported by a Physician from UNITED STATES on Apr 07, 2008. Male patient, weighting 166.0 lb, was diagnosed with non-small cell lung cancer stage i, cellulitis
, back pain and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia of chronic disease, blood potassium decreased, cellulitis , diarrhoea, dizziness , dyspepsia, dysphagia, dyspnoea, fatigue. Gemzar dosage: unknown. During the same period patient was treated with KEFLEX, CISPLATIN, FLOMAX, NICORETTE, HYDREA, VITAMIN B, OXYCODONE. Patient was hospitalized. Patient recovered.Gemzar Side Effects Report #4870924-X
Gemzar side effect was reported by a Physician from JAPAN on Dec 12, 2005. Male patient, 58 years of age, weighting 160.5 lb, was diagnosed with non-small cell lung cancer recurrent and was treated with Gemzar. After drug was administered, patient experienced the following side effects: dyspnoea, febrile neutropenia, infection
, influenza, interstitial lung disease, nasopharyngitis, oxygen saturation decreased, stridor. Gemzar dosage: 1350 MG, OTHER, INTRAVENOUS. During the same period patient was treated with DOCETAXEL, HARNAL, ACTOS, AMARYL, MAGNESIUM OXIDE, CODEINE PHOSPHATE, MEDICON. Patient was hospitalized. Patient recovered.Gemzar Side Effects Report #5150880-X
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 03, 2006. Male patient, 78 years of age, was diagnosed with non-small cell lung cancer metastatic, staphylococcal infection
and was treated with Gemzar. After drug was administered, patient experienced the following side effects: back pain , chills, dyspnoea, intervertebral discitis, pyrexia, staphylococcal infection . Gemzar dosage: unknown. During the same period patient was treated with ANTIBIOTICS. Patient was hospitalized. Patient recovered.Gemzar Side Effects Report #5925783-0
Gemzar side effect was reported by a Physician from BELGIUM on Oct 10, 2008. Male patient, 57 years of age, was diagnosed with non-small cell lung cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: dyspnoea, interstitial lung disease. Gemzar dosage: unknown. During the same period patient was treated with ALIMTA, MEDROL. Patient recovered.
Gemzar Side Effects Report #4738569-X
Gemzar side effect was reported by a Physician from GERMANY on July 14, 2005. Male patient, 81 years of age, weighting 211.6 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, alveolitis, arrhythmia
, cyanosis, dyspnoea, hypoxia, lung disorder, pneumocystis jiroveci infection. Gemzar dosage: 100 MG/M2. During the same period patient was treated with NAVOBAN, TRAMADOL. Patient was hospitalized. Patient died on 06/20/2005.Gemzar Side Effects Report #5646915-8
Gemzar side effect was reported by a Physician from UNITED STATES on Feb 24, 2008. Male patient, 75 years of age, weighting 185.0 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, dyspnoea, platelet count decreased, pneumonia
, white blood cell count decreased. Gemzar dosage: unknown. During the same period patient was treated with TARCEVA, INSPRA, COREG, DIABETA, ZOCOR. Patient was hospitalized. Patient recovered.Gemzar Side Effects Report #4705641-X
Gemzar side effect was reported by a Physician from on June 13, 2005. Male patient, 75 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alveolitis, chest x-ray abnormal, dyspnoea, hypoxia, pneumocystis jiroveci pneumonia. Gemzar dosage: 1000 MG/M2. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #4714062-5
Gemzar side effect was reported by a Physician from GERMANY on June 28, 2005. Male patient, 75 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alveolitis, cardiac failure, dyspnoea, hypoxia, pneumocystis jiroveci pneumonia, pulmonary fibrosis
. Gemzar dosage: 1000 MG/M2. Patient was hospitalized. Patient died on 06/01/2005.Gemzar Side Effects Report #5337810-2
Gemzar side effect was reported by a Physician from UNITED STATES on Jan 11, 2006. Male patient, 74 years of age, weighting 179.9 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, dyspnoea, haemoglobin decreased, platelet count decreased, platelet count increased, pulmonary toxicity, white blood cell count decreased, white blood cell count increased. Gemzar dosage: unknown. Patient recovered.
Gemzar Side Effects Report #4992605-4
Gemzar side effect was reported by a Health Professional from UNITED STATES on Jan 11, 2006. Male patient, 74 years of age, weighting 179.9 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, dyspnoea, haematocrit decreased, haemoglobin decreased, platelet count decreased, platelet count increased, pulmonary toxicity, white blood cell count decreased, white blood cell count increased. Gemzar dosage: 1800 MG. Patient recovered.
Gemzar Side Effects Report #4987631-5
Gemzar side effect was reported by a Physician from UNITED STATES on Apr 06, 2006. Male patient, 74 years of age, weighting 185.0 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: dyspnoea, lung infiltration, rash
. Gemzar dosage: 1000 MG/M2. During the same period patient was treated with CARBOPLATIN, PREDNISONE. Patient was hospitalized. Patient recovered.Gemzar Side Effects Report #6069136-6
Gemzar side effect was reported by a Physician from SWITZERLAND on Jan 29, 2009. Male patient, 73 years of age, weighting 156.5 lb, was diagnosed with non-small cell lung cancer, pulmonary embolism
and was treated with Gemzar. After drug was administered, patient experienced the following side effects: dyspnoea, pneumonitis, pulmonary embolism . Gemzar dosage: 1800 MG, UNK. During the same period patient was treated with CARBOPLATIN, AVASTIN, HEPARIN. Patient recovered.Gemzar Side Effects Report #5337811-4
Gemzar side effect was reported by a Physician from UNITED STATES on Jan 11, 2006. Female patient, 70 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood urea increased, dyspnoea, platelet count increased, pulmonary toxicity, white blood cell count increased. Gemzar dosage: unknown. During the same period patient was treated with ASA, VITAMINS, ASCORBIC ACID, COMPAZINE, SENOKOT, PREVACID, POTASSIUM CHLORIDE, MAGNESIUM. Patient recovered.
Gemzar Side Effects Report #4664888-1
Gemzar side effect was reported by a Physician from on May 02, 2005. Male patient, 70 years of age, weighting 132.3 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cardiomegaly, chest x-ray abnormal, dyspnoea, oxygen saturation decreased, pulmonary congestion. Gemzar dosage: 1500 MG OTHER. During the same period patient was treated with KYTRIL, MAXIPIME, MUCODYNE, OPSO. Patient recovered.
Gemzar Side Effects Report #4992655-8
Gemzar side effect was reported by a Physician from UNITED STATES on Jan 11, 2006. Female patient, 70 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood urea increased, dyspnoea, dyspnoea exacerbated, platelet count increased, pulmonary toxicity, white blood cell count increased. Gemzar dosage: unknown. During the same period patient was treated with ASA, VITAMINS, ASCORBIC ACID, COMPAZINE, SENOKOT, PREVACID, POTASSIUM CHLORIDE, MAGNESIUM. Patient recovered.
Gemzar Side Effects Report #5337603-6
Gemzar side effect was reported by a Health Professional from UNITED STATES on Sept 21, 2006. Male patient, 65 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: dyspnoea. Gemzar dosage: 1000 MG/M2, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #4710672-X
Gemzar side effect was reported by a Physician from JAPAN on June 20, 2005. Male patient, 65 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: asthma
, c-reactive protein increased, concomitant disease aggravated, dyspnoea, pneumonia . Gemzar dosage: 1000 MG/M2 OTHER. During the same period patient was treated with NAVELBINE. Patient died on 06/01/2005.Gemzar Side Effects Report #5234762-0
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 30, 2007. Female patient, 64 years of age, was diagnosed with non-small cell lung cancer, nausea
, anaemia, arthralgia and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, arthralgia, dyspnoea, pericardial effusion, pleuritic pain, vomiting. Gemzar dosage: unknown. During the same period patient was treated with CARBOPLATIN, ANTIEMETICS AND ANTINAUSEANTS, PROCRIT, GLUCOSAMINE. Patient recovered.Gemzar Side Effects Report #5237474-2
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 01, 2007. Female patient, 64 years of age, was diagnosed with non-small cell lung cancer, nausea
, anaemia, arthralgia, blood glucose abnormal and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, arthralgia, blood glucose increased, dyspnoea, insomnia, pain , pericardial effusion, pleuritic pain, somnolence. Gemzar dosage: unknown. During the same period patient was treated with CARBOPLATIN, ANTIEMETICS AND ANTINAUSEANTS, PROCRIT, GLUCOSAMINE, GLUCOTROL. Patient recovered.Gemzar Side Effects Report #5286548-9
Gemzar side effect was reported by a Physician from on Mar 28, 2007. Male patient, 59 years of age, weighting 211.6 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, dyspnoea, hypertensive crisis, respiratory acidosis. Gemzar dosage: 1600 MG, UNK. Patient died on 02/03/2007.
Gemzar Side Effects Report #5324837-X
Gemzar side effect was reported by a Physician from HUNGARY on May 04, 2007. Female patient, 59 years of age, weighting 92.59 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, asthenia, constipation
, decubitus ulcer, disease progression, dysphagia, dyspnoea, insomnia. Gemzar dosage: 2000 MG, UNK. During the same period patient was treated with CISPLATIN, METHYLPREDNISOLONE, RANITIDINE, METOPROLOL SUCCINATE. Patient was hospitalized. Patient died on 02/10/2007.Gemzar Side Effects Report #5328830-2
Gemzar side effect was reported by a Physician from on May 11, 2007. Male patient, 59 years of age, weighting 211.6 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, dyspnoea, hypertensive crisis, respiratory acidosis. Gemzar dosage: 1600 MG, UNK. Patient died on 02/03/2007.
Gemzar Side Effects Report #5341774-5
Gemzar side effect was reported by a Physician from on May 29, 2007. Male patient, 59 years of age, weighting 211.6 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, dyspnoea, hypertensive crisis, respiratory acidosis. Gemzar dosage: 1600 MG, UNK. Patient died on 02/03/2007.
Gemzar Side Effects Report #4698482-3
Gemzar side effect was reported by a Physician from on June 02, 2005. Male patient, 55 years of age, weighting 143.3 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood creatine phosphokinase mb increased, cardiomyopathy
, chest pain , dyspnoea, sinus tachycardia. Gemzar dosage: unknown. During the same period patient was treated with CISPLATIN, ONDANSETRON HYDROCHLORIDE. Patient was hospitalized. Patient recovered.Gemzar Side Effects Report #5245452-2
Gemzar side effect was reported by a Physician from AUSTRALIA on Feb 12, 2007. Female patient, 52 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: dyspnoea, pruritus, rash
, swollen tongue. Gemzar dosage: 2100 MG, OTHER. During the same period patient was treated with CISPLATIN. Patient recovered.Gemzar Side Effects Report #4806754-4
Gemzar side effect was reported by a Consumer or non-health professional from KOREA, REPUBLIC OF on July 07, 2005. Female patient, 50 years of age, weighting 119.0 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, arthralgia, dyspnoea, thrombocytopenia. Gemzar dosage: 450 MG/6. During the same period patient was treated with OXYCONTIN, ANZEMET, MACPERAN, MEGACE. Patient recovered.
Gemzar Side Effects Report #4831011-X
Gemzar side effect was reported by a Physician from KOREA, REPUBLIC OF on Oct 28, 2005. Female patient, 50 years of age, weighting 119.0 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, antinuclear antibody positive, arthralgia, bone scan abnormal, dyspnoea, osteolysis, rheumatoid factor positive, thrombocytopenia. Gemzar dosage: 1800 MG/12. During the same period patient was treated with CARBOPLATIN, OXYCONTIN, ANZEMET, MACPERAN, MEGACE. Patient recovered.
Gemzar Side Effects Report #5052103-9
Gemzar side effect was reported by a Health Professional from UNITED KINGDOM on June 22, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: bronchospasm, chest discomfort, dyspnoea. Gemzar dosage: 1250 MG. Patient recovered.
Gemzar Side Effects Report #5062447-2
Gemzar side effect was reported by a Health Professional from UNITED KINGDOM on July 07, 2006. Female patient, weighting 167.6 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: bronchospasm, chest discomfort, dyspnoea. Gemzar dosage: 2160 MG, UNK, INTRAVENOUS. During the same period patient was treated with CARBOPLATIN, LORAZEPAM, ZOPICLONE. Patient recovered.
Gemzar Side Effects Report #5816053-X
Gemzar side effect was reported by a Physician from UNITED KINGDOM on July 11, 2008. Male patient, weighting 191.8 lb, was diagnosed with non-small cell lung cancer, gout
, arthritis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alopecia, bone marrow failure, cellulitis , cough, dyspnoea, hyperhidrosis, mucosal inflammation, pulmonary oedema, rash erythematous. Gemzar dosage: 1250 MG/M2, 2740MG. During the same period patient was treated with NAPROXEN, ACETAMINOPHEN W, SERETIDE, COMBIVENT, OMEPRAZOLE, GABAPENTIN. Patient was hospitalized. Patient died on 01/17/2008.Gemzar Side Effects Report #5860047-5
Gemzar side effect was reported by a Physician from UNITED KINGDOM on Aug 13, 2008. Male patient, weighting 191.8 lb, was diagnosed with non-small cell lung cancer, gout
, arthritis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alopecia, bone marrow failure, cellulitis , cough, dyspnoea, hyperhidrosis, mucosal inflammation, pulmonary oedema, rash erythematous. Gemzar dosage: 1250 MG/M2, 2740MG. During the same period patient was treated with NAPROXEN, SERETIDE, COMBIVENT, OMEPRAZOLE, GABAPENTIN. Patient was hospitalized. Patient died on 01/17/2008.Gemzar Side Effects Report #5935934-X
Gemzar side effect was reported by a Physician from UNITED KINGDOM on Oct 20, 2008. Male patient, weighting 191.8 lb, was diagnosed with non-small cell lung cancer, arthritis
and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alopecia, bone marrow failure, cellulitis , cough, dyspnoea, hyperhidrosis, mucosal inflammation, pulmonary oedema, rash erythematous. Gemzar dosage: 1250 MG/M2, 2740MG. During the same period patient was treated with NAPROXEN, ACETAMINOPHEN W, SERETIDE, COMBIVENT, OMEPRAZOLE, GABAPENTIN. Patient was hospitalized. Patient died on 01/17/2008.Gemzar Side Effects Report #5977303-2
Gemzar side effect was reported by a Physician from UNITED KINGDOM on Nov 21, 2008. Male patient, weighting 205.0 lb, was diagnosed with non-small cell lung cancer, arthritis
and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alopecia, bone marrow failure, cellulitis , cough, dyspnoea, hyperhidrosis, mucosal inflammation, multi-organ failure. Gemzar dosage: 1250 MG/M2, 2740MG. During the same period patient was treated with NAPROXEN, ACETAMINOPHEN W, SERETIDE, COMBIVENT, OMEPRAZOLE, GABAPENTIN. Patient was hospitalized. Patient died on 01/17/2008.Gemzar Side Effects Report #4938549-5
Gemzar side effect was reported by a Physician from UNITED STATES on Feb 20, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: dyspnoea, influenza, respiratory distress. Gemzar dosage: unknown. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5038470-0
Gemzar side effect was reported by a Pharmacist from UNITED STATES on June 28, 2006. Male patient, 47 years of age, weighting 231.5 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: bronchiolitis, cough, diffuse alveolar damage, dyspnoea, interstitial lung disease, lung infiltration, pneumonia
. Gemzar dosage: 1000 MG/M2 (2300 MG). Patient was hospitalized. Patient recovered.Gemzar Side Effects Report #5152477-4
Gemzar side effect was reported by a Physician from UNITED STATES on Nov 06, 2006. Female patient, 45 years of age, was diagnosed with neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: dyspnoea, pulmonary embolism
, tachycardia. Gemzar dosage: unknown. Patient recovered.Gemzar Side Effects Report #5337808-4
Gemzar side effect was reported by a Health Professional from UNITED STATES on Jan 12, 2007. Female patient was diagnosed with neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: dyspnoea, influenza like illness, pulmonary toxicity, pyrexia. Gemzar dosage: unknown. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #4734995-3
Gemzar side effect was reported by a Pharmacist from UNITED STATES on July 15, 2005. Female patient, 43 years of age, weighting 200.6 lb, was diagnosed with metastatic neoplasm and was treated with Gemzar. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood chloride decreased, blood potassium decreased, crackles lung, dyspnoea, haematocrit decreased, haemoglobin decreased, hyperhidrosis. Gemzar dosage: 1000 MG/M2. During the same period patient was treated with IRINOTECAN. Patient recovered.
Gemzar Side Effects Report #6114826-X
Gemzar side effect was reported by a Physician from UNITED STATES on May 07, 2008. Male patient, 73 years of age, was diagnosed with metastatic carcinoma of the bladder and was treated with Gemzar. After drug was administered, patient experienced the following side effects: dyspnoea, pulmonary toxicity. Gemzar dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.
Gemzar Side Effects Report #4626575-5
Gemzar side effect was reported by a Physician from on Mar 14, 2005. Female patient, 55 years of age, weighting 149.9 lb, was diagnosed with metastases to lung and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, condition aggravated, dyspnoea, hypoxia, infection
, inflammation, lung infiltration, respiratory distress, urticaria. Gemzar dosage: 1000 MG/M2. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.Gemzar Side Effects Report #4681906-5
Gemzar side effect was reported by a Physician from on May 13, 2005. Male patient, 70 years of age, weighting 185.2 lb, was diagnosed with malignant neoplasm of renal pelvis, transitional cell carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood urea increased, cardiac failure congestive, dyspnoea, haemoglobin decreased, myocardial infarction, pulmonary oedema. Gemzar dosage: 1000 MG/M2. During the same period patient was treated with CISPLATIN, CARBOPLATIN, VERGENTAN. Patient died on 04/21/2005.
Gemzar Side Effects Report #4571180-2
Gemzar side effect was reported by a Physician from on Jan 19, 2005. Male patient, 54 years of age, weighting 143.3 lb, was diagnosed with lung neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anoxia, chills, cough, cyanosis, dyspnoea, hyperhidrosis, hypoxia, lymphangitis. Gemzar dosage: 1700 MG/1 OTHER. During the same period patient was treated with KYTRIL. Patient recovered.
Gemzar Side Effects Report #4607384-X
Gemzar side effect was reported by a Physician from on Feb 23, 2005. Male patient, 54 years of age, weighting 143.3 lb, was diagnosed with lung neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anoxia, chills, cough, cyanosis, dyspnoea, hyperhidrosis, hypoxia, lymphangitis. Gemzar dosage: 1700 MG/1 OTHER. During the same period patient was treated with KYTRIL. Patient recovered.
Gemzar Side Effects Report #5634403-4
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 08, 2008. Male patient, 48 years of age, was diagnosed with lung neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood pressure increased, cough, dyspnoea, flushing, heart rate increased, hypersensitivity, infection
, lung disorder, pneumonia . Gemzar dosage: unknown. During the same period patient was treated with CISPLATIN, AVASTIN. Patient was hospitalized. Patient recovered.Gemzar Side Effects Report #5531956-1
Gemzar side effect was reported by a Physician from FRANCE on Nov 23, 2007. Male patient was diagnosed with lung neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, dysphagia, dyspnoea, face oedema, localised oedema, thrombocytopenia. Gemzar dosage: unknown. During the same period patient was treated with CARBOPLATIN, DEPAKINE CHRONO, TANAKAN, LEVOTHYROX. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5631979-8
Gemzar side effect was reported by a Physician from BRAZIL on Feb 12, 2008. Female patient, weighting 149.9 lb, was diagnosed with lung cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: dyspnoea, feeling hot, flushing, malaise. Gemzar dosage: unknown. Patient recovered.
Gemzar Side Effects Report #4788760-1
Gemzar side effect was reported by a Physician from FRANCE on Sept 20, 2005. Female patient, 59 years of age, weighting 123.5 lb, was diagnosed with lung adenocarcinoma metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: chronic obstructive pulmonary disease, dyspnoea, hypersensitivity, livedo reticularis, oxygen saturation decreased, pneumonia
, rash , renal failure, tachycardia. Gemzar dosage: 865 MG/M2/2 OTHER. During the same period patient was treated with CISPLATIN, MORPHINE SULPHATE. Patient was hospitalized. Patient died on 05/20/2005.Gemzar Side Effects Report #4565358-1
Gemzar side effect was reported by a Pharmacist from on Jan 07, 2005. Female patient, 62 years of age, was diagnosed with lung adenocarcinoma, lung cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, disease progression, dyspnoea, fibrosis, hypoxia, pneumonia
, pulmonary toxicity. Gemzar dosage: 1680 MG. During the same period patient was treated with TAXOTERE. Patient died on 12/13/2004.Gemzar Side Effects Report #4611199-6
Gemzar side effect was reported by a Consumer or non-health professional from on Jan 21, 2004. Female patient, 57 years of age, was diagnosed with leiomyosarcoma recurrent, neoplasm prophylaxis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cough, dyspnoea. Gemzar dosage: unknown. Patient was hospitalized. Patient recovered.